IDIX
Idenix Pharmaceuticals Inc
Biopharmaceutical company developing antiviral treatments
CUSIP: 45166R204HealthcareUS1 holder
Total Value
$302.84M
Total Shares
53.33M
Net Share Change
+16.42M
Activity
1 buying
Investor
Value
Shares
Weight
Change
Baupost Group LLC
$302.84M53.33M shares
ADD+16.42M(+44.5%)